Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.36 |
| ▸ | PRKDC | P78527 | 3/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.35 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.34 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.34 |
| ▸ | QPCT | Q16769 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29138851 | 1.00 | LRRK2 (0.39) | LRRK2PIK3C3PRKDCFFAR4HCRTR1 | |
| SCHEMBL29138939 | 0.82 | LMNA (0.36) | HCRTR1HCRTR2EPHX2 | |
| SCHEMBL29138905 | 0.82 | LMNA (0.36) | HCRTR1HCRTR2EPHX2 | |
| SCHEMBL29138873 | 0.82 | PRKDC (0.41) | LRRK2PIK3C3PRKDCHCRTR1HCRTR2 | |
| SCHEMBL29138877 | 0.82 | PRKDC (0.41) | LRRK2PIK3C3PRKDCHCRTR1HCRTR2 | |
| SCHEMBL29138818 | 0.77 | GRM2 (0.37) | PIK3C3PRKDCFFAR4GRM2EPHX2 | |
| SCHEMBL29138853 | 0.77 | GRM2 (0.37) | PIK3C3PRKDCFFAR4GRM2EPHX2 | |
| SCHEMBL29138888 | 0.72 | ALDH1A1 (0.39) | — | |
| SCHEMBL29138847 | 0.72 | ALDH1A1 (0.39) | — | |
| SCHEMBL29138864 | 0.70 | AR (0.36) | PIK3C3EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116888120-A | PRMTS inhibitors | 美国安进公司 | 2023-10-13 | — | — | CN | disclosed |